Recent Advances in Wafer Delivery: Chemistry, Manufacturing, and Control

Wafer drug delivery offers a promising approach to personalized medicine by enabling precise dosage adjustments, controlled release rates, and tailored drug responses. By carefully selecting the composition, wafers can optimize therapeutic outcomes for individual patients. The development of a wafer formulation involves choosing the appropriate active ingredients, excipients, and drug compounds, which directly impact stability, solubility, and release profile of the drug. This study addresses the essential components and characteristics required for formulating an optimized wafer product, alongside the critical control steps necessary for its evaluation. Additionally, the manufacturing process plays a key role in maintaining quality standards by ensuring consistent drug content, uniformity, and dissolution properties. Ultimately, thorough characterization and monitoring of wafer quality are vital to guarantee safety, efficacy, and stability. We begin by reviewing ongoing clinical trials and existing products currently available in the wafer market.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Sciences
Published
2026-01-05
DOI
https://doi.org/10.34172/ps.026.40987
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent Advances in Wafer Delivery: Chemistry, Manufacturing, and Control

Ali Rajabi Zangi, Ali Azizi, Yousef Javadzadeh, Fatemeh Soltanmohammadi et al.
Pharmaceutical Sciences
Advanced Drug Delivery Systems
article

Recent Advances in Wafer Delivery: Chemistry, Manufacturing, and Control

Ali Rajabi Zangi, Ali Azizi, Yousef Javadzadeh, Fatemeh Soltanmohammadi, Zohreh Asadi, Mohammad Sheibani
article en

Abstract

Wafer drug delivery offers a promising approach to personalized medicine by enabling precise dosage adjustments, controlled release rates, and tailored drug responses. By carefully selecting the composition, wafers can optimize therapeutic outcomes for individual patients. The development of a wafer formulation involves choosing the appropriate active ingredients, excipients, and drug compounds, which directly impact stability, solubility, and release profile of the drug. This study addresses the essential components and characteristics required for formulating an optimized wafer product, alongside the critical control steps necessary for its evaluation. Additionally, the manufacturing process plays a key role in maintaining quality standards by ensuring consistent drug content, uniformity, and dissolution properties. Ultimately, thorough characterization and monitoring of wafer quality are vital to guarantee safety, efficacy, and stability. We begin by reviewing ongoing clinical trials and existing products currently available in the wafer market.

Pharmaceutical SciencesVol. 32(1)
Iran University of Medical Sciences (IR), Tabriz University of Medical Sciences (IR), Arak University (IR), Shahid Beheshti University of Medical Sciences (IR)
Openalex Percentile: Top 70%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.